SCHEMBL7301461

SCHEMBL7301461

CC(=O)OCc1cccc2sc(-c3ccccc3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 1/20 0.45
ALOX5 P09917 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
PKM P14618 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TRPM8 Q7Z2W7 2/20 0.42
CDC7 O00311 1/20 0.42
DBF4 Q9UBU7 1/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 4/20 0.41
MAPT P10636 1/20 0.41
APP P05067 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301025 0.80 CYP1A2 (0.48) CYP1A2CYP2C19ALDH1A1ALOX5SMN1; SMN2
SCHEMBL9130844 0.78 ADORA3 (0.45) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL28312994 0.75 KDM4E (0.43) CYP2C19ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7299628 0.75 APP (0.41) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL13647424 0.74 TRPM8 (0.57) ALDH1A1ALOX5SMN1; SMN2NPC1RAB9A
SCHEMBL13034172 0.74 RAB9A (0.67) CYP1A2CYP2C19ALDH1A1ALOX5SMN1; SMN2
SCHEMBL900790 0.73 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2NPC1RAB9ANFKB1
SCHEMBL31733024 0.72 CYP1A2 (0.41) CYP1A2CYP2C19ALDH1A1RAB9AKDM4E
SCHEMBL8676810 0.71 CYP1A2 (0.41) CYP1A2CYP2C19ALDH1A1ALOX5RAB9A
SCHEMBL5255523 0.70 ALDH1A1 (0.65) CYP1A2CYP2C19ALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0450420-B1 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments BAYER AG (DE) 1994-09-21 EP disclosed
US-5254692-A Inotropic BAYER AKTIENGESELLSCHAFT (DE) 1993-10-19 US disclosed
US-5200420-A Inotropic agents for cardiovascular disorders BAYER AKTIENGESELLSCHAFT (DE) 1993-04-06 US disclosed
EP-0450420-A2 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments BAYER AG (DE) 1991-10-09 EP disclosed